|
¿¡ÀÌÇÁ·ÎÁ¨Æĸ¶(ÁÖ) |
¼¿ï°æ±âÁö¿ªMRä¿ëÇÕ´Ï´Ù
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
10.01 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
Clinical Lead (for Dedicated CRA) ¸ðÁý -ÆĶô¼¿ÄÚ¸®¾Æ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
07.16 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
Dedicated CRA / CRA ¸ðÁý -ÆĶô¼¿ÄÚ¸®¾Æ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
07.16 |
|
|
PSI CRO Korea |
[PSI CRO Korea] ä¿ë Á¤º¸
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.31 |
|
|
°³²Â÷º´¿ø |
°³²Â÷º´¿ø ¾ß°£¾à»ç Ãʺù ¾È³»
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
05.11 |
|
|
(ÁÖ)¾¾¿£¾Ë¸®¼Ä¡ |
¾¾¿£¾Ë¸®¼Ä¡ °³², ºÎ»ê [°æ·Â] CRA ä¿ë
¼¿ï °³²±¸, ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.06 |
|
|
¿Ã¸®ºêÀ¯´Ï¿Â |
º¸Ã»±â ÀÇ·á±â±â ¿µ¾÷»ó´ã
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
»ó½Ãä¿ë |
07.19 |
|
|
(ÁÖ)¼¼Á¾¾¾¾Ë¿À |
¼¼Á¾CRO - RA (Regulatory Affairs) ½ÅÀÔ ¹× °æ·ÂÀÚ ¸ðÁý
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
07.23 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.02 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
03.02 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
08.18 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
06.01 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
03.19 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.19 |
|
|
À¯´Ï¸ÞµåÁ¦¾àÁÖ½Äȸ»ç |
ÀÓ»óÇмúÆÀ ÀÓ»óÆÄÆ® °æ·ÂÁ÷ ¸ðÁý
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
02.16 |
|